Trends in meningococcal disease in the United States military, 1971-2010

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1430-1437

  Broderick, Michael P ^a   Faix, Dennis J ^a   Hansen, Christian J ^a   Blair, Patrick J ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADOLESCENT; ADULT; ARMY; ARTICLE; CLINICAL ARTICLE; DRUG FATALITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INCIDENCE; MALE; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PREVALENCE; UNITED STATES; VACCINATION; VACCINE FAILURE;

ADOLESCENT; ADULT; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MENINGOCOCCAL INFECTIONS; MILITARY MEDICINE; MILITARY PERSONNEL; NEISSERIA MENINGITIDIS; SEROTYPING; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84865328783     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.120257     Document Type: Article

References (18)

1. Brundage JF, Ryan MA, Feighner BH, Erdtmann FJ. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specifi c components, 1964-1998. Clin Infect Dis. 2002;35:1376-1381. http:// dx.doi.org/10.1086/344273
2. Brundage JF, Zollinger WD. Evolution of meningococcal disease epidemiology in the US Army. In: Vedros NA, editor. Evolution of meningococcal disease, vol. I. Boca Raton (FL): CRC Press; 1987. p. 1885-1921.
3. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network, Neisseria meningitidis, 2009. 2010 [cited 2012 Jun 12]. http://www. cdc.gov/abcs/reports-findings/survreports/mening09.pdf
4. Armed Forces Epidemiological Board Infectious Diseases Control Subcommittee. Vaccines in the military: a Department of Defense-wide review of vaccine policy and practice. A report of the Infectious Diseases Control Subcommittee of the Armed Forces Epidemiological Board. Falls Church (VA): The Board; 1999.
5. Centers for Disease Control and Prevention. Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-7):13-20.
6. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;49(RR-7):1-10. PMID:10902834
7. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense Serum Repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92:1900-1904. http://dx.doi.org/10.2105/AJPH.92.12.1900
8. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. Lyon (France): International Agency for Research on Cancer; 1987.
9. Young LS, LaForce FM, Head JJ, Feeley JC, Bennett J V. A simultaneous outbreak of meningococcal and infl uenza infections. N Engl J Med. 1972;287:5-9. http://dx.doi.org/10.1056/ NEJM197207062870102
10. Moore PS, Hierholzer J, DeWitt W, Gouan K, Djore D, Lippeveld T, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA. 1990;264:1271-1275. http://dx.doi.org/10.1001/jama.1990.03450100061026
11. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344:1378-1388. http:// dx.doi.org/10.1056/NEJM200105033441807
12. Crum N, Chapman FA, Russell KL, Hale BR. The many faces of meningococcal disease: a case series and review of presentations and treatment options. Infect Dis Clin Pract. 2005;13:5-9. http:// dx.doi.org/10.1097/01.idc.0000152474.47425.5b
13. Artenstein MS, Rust JH Jr, Hunter DH, Lamson TH, Buescher EL. Acute respiratory disease and meningococcal infection in army recruits. JAMA. 1967;201:1004-1007. http://dx.doi.org/10.1001/ jama.1967.03130130030008
14. Keyserling HL, Pollard AJ, DeTora LM, Gilmet GP. Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135. Expert Rev Vaccines. 2006;5:445-459. http://dx.doi.org/10.1586/14760584.5.4.445
15. Auckland C, Gray S, Borrow R, Andrews N, Goldblatt D, Ramsay M, et al. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis. 2006;194:1745-1752. http://dx.doi.org/10.1086/509619
16. Centers for Disease Control and Prevention. Updated recommendations for use of meningococcal conjugate vaccines- Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011;60:72-76.
17. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2005;54(RR-7):1-21.
18. Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA. 2001;286:688-693. http://dx.doi.org/10.1001/ jama.286.6.688